 |
|
|
|
 |
|
|
| Article 1 to 10 out of 17 concerning ITI Life Sciences
|
-
ITI Life Sciences Seeks to Fund Innovative R&D Programme in Synthetic Biology, focusing on Gene & Genome Synthesis and Assembly
(04/04/2008)
ITI Life Sciences issued a Call for Expressions of Interest from organisations or individuals with expertise in Synthetic Biology techniques that could be applied to Gene & Genome Synthesis and Assembly. ITI Life Sciences' is seeking to commission a ...
-
Success in ITI Life Sciences research programme leads to extension and further funding of £2 million
(02/27/2008)
30 novel transgenic models created to predict the effects of drug compounds in the human body
ITI Life Sciences announced it will be extending its research programme designed to develop new technologies for use in the pharmaceutical industry to predict the effects of drug compounds in the human body. The research programme, which has ...
-
ITI Life Sciences Appoints Dr Ford Kennedy as Director of Commercialisation
(01/29/2008)
ITI Life Sciences announced the appointment of Dr Ford Kennedy as its new Director of Commercialisation. Dr Kennedy has extensive commercial experience in the bioscience industry from a career in business development, sales and marketing and ...
-
Heriot-Watt University Becomes Third Scottish University to Join ITI Life Sciences' Stem Cell Technologies R&D Programme
(08/03/2007)
ITI Life Sciences announced that Heriot-Watt University (Heriot-Watt) has joined its £9.5 million Stem Cell Technologies (SCT) R&D programme, which started in January 2007.Heriot-Watt will join two other Scottish universities (Glasgow and Dundee) ...
-
ITI Life Sciences appoints Eleanor Mitchell as Managing Director
(06/26/2007)
ITI Life Sciences announced the appointment of Dr Eleanor Mitchell as Managing Director as part of the wider reorganisation of ITI Scotland, its parent group.Over the past 18 months, Dr Mitchell, in her former role of Acting CEO of ITI Life ...
-
ITI Life Sciences Seeks to Fund Innovative Drug Discovery Programme based on Ubiquitin
(05/24/2007)
Following the publication of its comprehensive foresighting report on Emerging Drug Targets, ITI Life Sciences issues a Call for Expressions of Interest from organisations or individuals with expertise in the field of Ubiquitin Signalling. ITI Life ...
-
Leading Scottish University Joins ITI Life Sciences' Stem Cell Technologies R&D Programme
(05/09/2007)
Dundee University to provide additional research expertise to progress SCT programme
ITI Life Sciences announced that it has reached its first technical milestone in its Stem Cell Technologies (SCT) R&D programme, and as a result Dundee University has joined the £9.5 million programme, which started in January 2007.Dundee University ...
-
ITI Life Sciences licenses technology to Cognia to develop a database product to enhance drug discovery and development
(03/22/2007)
ITI Life Sciences announced the signing of a commercialisation licence with Cognia EU Ltd. The new licence will enable Cognia to develop a new database product that will streamline researchers' access to essential scientific information. Initially ...
-
ITI Life Sciences signs commercialisation licence agreements with Edinburgh Instruments and Almac Sciences (Scotland) Ltd
(03/01/2007)
ITI Life Sciences announced the signing of two Commercialisation Licence agreements based on intellectual assets created during ITI Life Sciences' Fluorescence Lifetime Assay Programme, using fluorescence lifetime for 3-D cell-based assays and other ...
-
ES Cell International and ITI Life Sciences sign Licence Agreement for use of novel Stem Cell Technologies
(01/31/2007)
ES Cell International Pte Ltd (ESI) and ITI Life Sciences announced the signing of a non-exclusive Research Licence Agreement. No financial details were disclosed. The licence involves two British patents granted to ESI that cover aspects of hES ...
Additional information
ITI Life Sciences
Dundee, United Kingdom
Company
|
|
|
|
|
|
Top
